Extranodal NK-T-cell lymphoma historical perspective: Difference between revisions
No edit summary |
No edit summary |
||
Line 8: | Line 8: | ||
*Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic [[granuloma]]<ref name="pmid31041299">{{cite journal| author=Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T| title=Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. | journal=Front Pediatr | year= 2019 | volume= 7 | issue= | pages= 141 | pmid=31041299 | doi=10.3389/fped.2019.00141 | pmc=6476925 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31041299 }} </ref> | *Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic [[granuloma]]<ref name="pmid31041299">{{cite journal| author=Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T| title=Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress. | journal=Front Pediatr | year= 2019 | volume= 7 | issue= | pages= 141 | pmid=31041299 | doi=10.3389/fped.2019.00141 | pmc=6476925 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31041299 }} </ref> | ||
*The natural history of Extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "Rhinitis Gangrenosa Progressiva" | *The natural history of Extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "Rhinitis Gangrenosa Progressiva"<ref name="pmid1787378">{{cite journal| author=McBride P| title=Photographs of a case of rapid destruction of the nose and face. 1897. | journal=J Laryngol Otol | year= 1991 | volume= 105 | issue= 12 | pages= 1120 | pmid=1787378 | doi=10.1017/s0022215100118407 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1787378 }}</ref> | ||
*First known case of Natural-Killer-cell lymphoma was a 19-years old man, with a tumor affecting nasal cavity.<ref name="pmid14736941">{{cite journal| author=Schrader C, Janssen D, Kneba M, Lennert K| title=A 38-year history of natural-killer-cell lymphoma. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 4 | pages= 418-9 | pmid=14736941 | doi=10.1056/NEJM200401223500423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14736941 }} </ref> | *First known case of Natural-Killer-cell lymphoma was a 19-years old man, with a tumor affecting nasal cavity.<ref name="pmid14736941">{{cite journal| author=Schrader C, Janssen D, Kneba M, Lennert K| title=A 38-year history of natural-killer-cell lymphoma. | journal=N Engl J Med | year= 2004 | volume= 350 | issue= 4 | pages= 418-9 | pmid=14736941 | doi=10.1056/NEJM200401223500423 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14736941 }} </ref> | ||
* Natural-Killer-cell lymphoma was diagnosed as "Granuloma Gangraenescens" which was considered as unclassified [[sarcoma]]. | * Natural-Killer-cell lymphoma was diagnosed as "Granuloma Gangraenescens" which was considered as unclassified [[sarcoma]]. |
Revision as of 14:22, 22 August 2019
Extranodal NK-T-cell lymphoma Microchapters |
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Extranodal NK-T-cell lymphoma historical perspective On the Web |
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma historical perspective |
Extranodal NK-T-cell lymphoma historical perspective in the news |
Blogs on Extranodal NK-T-cell lymphoma historical perspective |
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2]
Overview
First known case of Natural-Killer-cell lymphoma was diagnosed in a 19-years old boy. The diagnosis of Natural-Killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
Historical Perspective
- Extranodal NK cell lymphoma probably was first reported by McBride as a disease which rapidly destructs nose and face with progressing necrotic granuloma[1]
- The natural history of Extranodal NK cell lymphoma was generally aggressive and lethal, this disease was initially termed as "Rhinitis Gangrenosa Progressiva"[2]
- First known case of Natural-Killer-cell lymphoma was a 19-years old man, with a tumor affecting nasal cavity.[3]
- Natural-Killer-cell lymphoma was diagnosed as "Granuloma Gangraenescens" which was considered as unclassified sarcoma.
- The diagnosis of Natural-Killer-cell lymphoma was confirmed by pathology as Wegener's Granulomatosis was ruled out.
- 33 years later, in 1998, the patient had a relapse with skin lesions which progressed with nasal involvement in 2002, and the final mortal relapse was in 2003 with the leukemic disease.
- Reanalysis of stored slides of 1965 revealed an immunophenotype typical of NK cell which was similar to those found in 1998 skin lesions, 2002 nasal tissue, and 2003 blood.
- Biopsy specimen collected in 1998 and 2002 contained EBV virus encoded RNA transcripts and then diagnosed as a Natural-killer-cell lymphoma.
References
- ↑ Harabuchi Y, Takahara M, Kishibe K, Nagato T, Kumai T (2019). "Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: Basic Science and Clinical Progress". Front Pediatr. 7: 141. doi:10.3389/fped.2019.00141. PMC 6476925. PMID 31041299.
- ↑ McBride P (1991). "Photographs of a case of rapid destruction of the nose and face. 1897". J Laryngol Otol. 105 (12): 1120. doi:10.1017/s0022215100118407. PMID 1787378.
- ↑ Schrader C, Janssen D, Kneba M, Lennert K (2004). "A 38-year history of natural-killer-cell lymphoma". N Engl J Med. 350 (4): 418–9. doi:10.1056/NEJM200401223500423. PMID 14736941.